Filing Details
- Accession Number:
- 0001140361-14-011225
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-05 16:40:37
- Reporting Period:
- 2014-03-03
- Filing Date:
- 2014-03-05
- Accepted Time:
- 2014-03-05 16:40:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238403 | K Daniel Spiegelman | 105 Digital Drive Novato CA 94949 | Evp, Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-03-03 | 8,000 | $39.06 | 72,273 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-03-03 | 8,000 | $80.32 | 64,273 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2014-03-03 | 8,000 | $0.00 | 8,000 | $39.06 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 71,000 | 2012-11-29 | 2022-05-28 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to a Rule 10b5-1 plan executed on December 9, 2013.
- The price in Column 4 is a weighted average price. The prices actually received ranged from $79.56 to $81.21. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- Option grant vests 6/48ths on November 29, 2012 and 1/48th on the 29th day of every month thereafter.
- Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.
Billionaire Hedge Funds
